Metadon Nordic Drugs (Methadone Hydrochloride)

Methadone works by binding tightly to the µ‑opioid receptors in the central nervous system, acting as a full agonist. This activation reduces the perception of pain and suppresses the physiological response to opioid withdrawal, while its long half‑life provides stable plasma concentrations that support once‑daily dosing in maintenance therapy.

The dose of methadone is individualized. A qualified prescriber determines the appropriate starting dose, titration schedule, and maintenance level based on the patient’s clinical condition, prior opioid exposure, and response to therapy. No generic dosing regimen is provided here.

Methadone is classified as Pregnancy Category C, indicating that risk cannot be ruled out. It may be used when the potential benefit justifies the potential risk to the fetus. Methadone does pass into breast milk, so breastfeeding decisions should be made in consultation with a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials. The sales team then replies with pricing, availability, shipping details and any required import documentation.

Both methadone and buprenorphine are opioid agonists used for dependence treatment, but methadone is a full µ‑opioid receptor agonist with a longer half‑life, while buprenorphine is a partial agonist with a ceiling effect on respiratory depression. Methadone may provide more consistent analgesia for severe pain, whereas buprenorphine often has a lower risk of overdose.

Methadone tablets should be stored at ambient temperature, preferably below 25 °C, in the original packaging to protect from moisture and light. Keep the product out of reach of children and do not store in areas with high humidity or direct sunlight.

Methadone is administered orally, typically as a tablet or liquid formulation. The medication is taken with or without food, according to the prescriber’s instructions, and dosing intervals are usually once daily for maintenance therapy, though adjustments may be made based on clinical response.

The most serious risks include respiratory depression, which can be life‑threatening, especially when combined with other CNS depressants; cardiac arrhythmias such as QT‑interval prolongation; and severe allergic reactions that may lead to anaphylaxis. Patients should be monitored closely for these events, particularly during dose changes.

Methadone is contraindicated in individuals with known hypersensitivity to methadone, those with severe respiratory insufficiency, uncontrolled asthma, or significant cardiac conduction abnormalities. It should also be avoided in patients taking certain potent CYP3A4 inhibitors without careful monitoring.